Patent - Abbreviated New Drug Application Cases filed in Delaware
Cases 31 - 40 of 75
Boehringer Ingelheim Pharmaceuticals Inc. v. Lupin Ltd. et al
as 1:2021cv01486
Plaintiff: Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation
Defendant: Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
ViiV Healthcare Company et al v. Lupin Limited et al
as 1:2021cv01561
Plaintiff: ViiV Healthcare Company, Shionogi & Co., Ltd. and ViiV Healthcare UK (No. 3) Limited
Defendant: Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Neurocrine Biosciences, Inc. v. Lupin Limited et al
as 1:2021cv01408
Plaintiff: Neurocrine Biosciences, Inc.
Defendant: Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc. and others
Cause Of Action: 35 U.S.C. § 271
Supernus Pharmaceuticals, Inc. v. Lupin Limited et al We have downloadable decisions or orders for this case
as 1:2021cv01293
Plaintiff: Supernus Pharmaceuticals, Inc.
Defendant: Lupin Limited, Lupin Atlantis Holdings S.A., Nanomi B.V. and others
Cause Of Action: 28 U.S.C. § 1338
Vertex Pharmaceuticals Incorporated v. Lupin Limited et al
as 1:2021cv01019
Counter Defendant: Vertex Pharmaceuticals Incorporated
Counter Claimant: Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Neurocrine Biosciences, Inc. v. Lupin Limited et al
as 1:2021cv01042
Plaintiff: Neurocrine Biosciences, Inc.
Defendant: Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc. and others
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co., Ltd. v. Lupin Limited et al We have downloadable decisions or orders for this case
as 1:2021cv00900
Defendant: Lupin Pharmaceuticals, Inc. and Lupin Limited
Plaintiff: Otsuka Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Lupin Ltd. et al
as 1:2021cv00530
Defendant: Lupin Pharmaceuticals, Inc. and Lupin Ltd.
Plaintiff: Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Astellas Pharma Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2021cv00425
Defendant: Teva Pharmaceuticals USA, Inc., Cadila Healthcare Ltd. doing business as Zydus Cadila, Actavis LLC and others
Plaintiff: Astellas Pharma Global Development, Inc., Astellas Pharma Inc. and Astellas Ireland Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
Bayer Pharma AG et al v. Lupin Limited et al
as 1:2021cv00314
Plaintiff: Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant: Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?